C.M. Bidwell & Associates’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.85K Hold
177
﹤0.01% 355
2025
Q4
$3.81K Hold
177
﹤0.01% 360
2025
Q3
$3.41K Hold
177
﹤0.01% 373
2025
Q2
$3.03K Buy
+177
New +$7.55K ﹤0.01% 366
2024
Q3
Sell
-4
Closed -$632 542
2024
Q2
$632 Hold
4
﹤0.01% 429
2024
Q1
$518 Hold
4
﹤0.01% 440
2023
Q4
$386 Sell
4
-1,549
-100% -$149K ﹤0.01% 461
2023
Q3
$188K Sell
1,553
-28
-2% -$3.17K 0.14% 122
2023
Q2
$181K Hold
1,581
0.13% 133
2023
Q1
$218K Sell
1,581
-97
-6% -$12.6K 0.17% 106
2022
Q4
$217K Hold
1,678
0.17% 114
2022
Q3
$185K Buy
1,678
+1,058
+171% +$107K 0.15% 122
2022
Q2
$46K Buy
620
+590
+1,967% +$43.4K 0.04% 283
2022
Q1
$2K Sell
30
-1,615
-98% -$124K ﹤0.01% 483
2021
Q4
$148K Buy
+1,645
New +$141K 0.09% 205

Other funds holding SRPT